Shagufta Shaheen, S. Otoukesh, B. Jabo, Manmeet Kaur, Nicole D Wheeler, S. Mirshahidi, S. Zaheer, H. Mirshahidi
{"title":"少即是多:视频辅助胸外科手术(VATS)与开胸手术(OT)在可切除肺癌治疗中的应用","authors":"Shagufta Shaheen, S. Otoukesh, B. Jabo, Manmeet Kaur, Nicole D Wheeler, S. Mirshahidi, S. Zaheer, H. Mirshahidi","doi":"10.4172/2329-6771.1000216","DOIUrl":null,"url":null,"abstract":"Lung cancer is the leading cause of cancer-related mortalities around the world [1]. Potentially curable early stage Non-Small-Cell Lung Cancer (NSCLC) can be found in one-third of this patient population [2]. Surgical resection remains the backbone of treatment in resectable lung cancers. The introduction of VATS in 1994 [3] sparked interest in minimally invasive tumor resection. VATS has also been shown to have fewer postoperative complications [4] and has been associated with decreased postoperative pain and increased quality of life compared to OT [5]. Several studies have compared these two approaches indirectly, but no randomized controlled trial has investigated the long-term effect on outcomes. We aim to investigate the long-term Disease-Free Survival (DFS) and OS of patients with lung cancer undergoing lung resection by OT or VATS for resectable stage lung cancer. Patients and Methods","PeriodicalId":16252,"journal":{"name":"Journal of Integrative Oncology","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Less is More: Video-Assisted Thoracic Surgery (VATS) vs. Open Thoracotomy (OT) in the Management of Resectable Lung Cancer\",\"authors\":\"Shagufta Shaheen, S. Otoukesh, B. Jabo, Manmeet Kaur, Nicole D Wheeler, S. Mirshahidi, S. Zaheer, H. Mirshahidi\",\"doi\":\"10.4172/2329-6771.1000216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lung cancer is the leading cause of cancer-related mortalities around the world [1]. Potentially curable early stage Non-Small-Cell Lung Cancer (NSCLC) can be found in one-third of this patient population [2]. Surgical resection remains the backbone of treatment in resectable lung cancers. The introduction of VATS in 1994 [3] sparked interest in minimally invasive tumor resection. VATS has also been shown to have fewer postoperative complications [4] and has been associated with decreased postoperative pain and increased quality of life compared to OT [5]. Several studies have compared these two approaches indirectly, but no randomized controlled trial has investigated the long-term effect on outcomes. We aim to investigate the long-term Disease-Free Survival (DFS) and OS of patients with lung cancer undergoing lung resection by OT or VATS for resectable stage lung cancer. Patients and Methods\",\"PeriodicalId\":16252,\"journal\":{\"name\":\"Journal of Integrative Oncology\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Integrative Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2329-6771.1000216\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-6771.1000216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Less is More: Video-Assisted Thoracic Surgery (VATS) vs. Open Thoracotomy (OT) in the Management of Resectable Lung Cancer
Lung cancer is the leading cause of cancer-related mortalities around the world [1]. Potentially curable early stage Non-Small-Cell Lung Cancer (NSCLC) can be found in one-third of this patient population [2]. Surgical resection remains the backbone of treatment in resectable lung cancers. The introduction of VATS in 1994 [3] sparked interest in minimally invasive tumor resection. VATS has also been shown to have fewer postoperative complications [4] and has been associated with decreased postoperative pain and increased quality of life compared to OT [5]. Several studies have compared these two approaches indirectly, but no randomized controlled trial has investigated the long-term effect on outcomes. We aim to investigate the long-term Disease-Free Survival (DFS) and OS of patients with lung cancer undergoing lung resection by OT or VATS for resectable stage lung cancer. Patients and Methods